Getting your soft gels just right

Soft capsules, also known as soft gels, are a growth market. But producing them is challenging. Getting the formulation just right, while ensuring production efficiency and effective API delivery, calls for in-depth understanding of the soft gel market and the capsule production process. At Rousselot Functional Ingredients we can provide you with the support you need to succeed.

Advantages of capsules over other delivery forms

  • A simpler manufacturing process with fewer production steps
  • The possibility to encapsulate most types of, semisolid, and liquid fill formulations
  • Unique color and shape configurations for enhancing product identity
  • Easy to swallow and neutral in odor and flavor, improving patient compliance
  • Good delivery form

The main excipient in a growing market

  • The soft gel market is expected to grow by 7,9% from 2022 to 2030 (source: Softgel Capsules Market Size Report, 2022 – 2030)
  • The main growth drivers:
    Soft gel’s popularity in the nutraceutical market
    Its added value for difficult formulations
  • Gelatin is the main excipient in soft gelatin capsules, due to its unique functional capabilities and full dissolution properties

Unlimited innovation possibilities in soft capsules

A safe and natural excipient, the gelatins provided by Rousselot Functional Ingredients offer unlimited innovation options in the soft capsules market – whether in chewable capsules or nutraceuticals. With our range of pharmaceutical gelatins for soft capsules, you can adjust encapsulation conditions to the encapsulated formula and active compounds.

New white paper: Unlock next generation soft gels and gummies

This white paper provides guidance on how to choose the right excipient for innovation. Learn more about the growing popularity of soft capsules (also known as soft gels) and gummies, as well as the potential of gummy caps – a new gummy delivery format featuring a liquid-center fill.

StabiCaps™, the proven solution for more stable soft gels

When manufacturing soft gels, nutra and pharmaceutical manufacturers sometimes experience shell cross-linking leading to stability issues. Developed by Rousselot Functional Ingredients, StabiCaps gelatins enable the production of capsules with reduced cross-linking. StabiCaps consist of a patented range of gelatins offering shell stability and API release levels superior to those of standard gelatins.